Establishing a center for technology transfer and entrepreneurial research in Puerto Rico.
Official title: UPR Center for Incubator and Technology Transfer (UPRCITT)
Funded at University of Puerto Rico · NIH-10793133 · Data updated 2026-11-12
This study is all about creating a special space at the University of Puerto Rico where scientists can work together on exciting projects like nanotechnology and vaccines, helping to spark new ideas and job opportunities in the biotech and pharmaceutical fields for the community.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Puerto Rico NIH-funded |
| Lab location | 1 site (San Juan, United States) |
| Project start | September 15, 2023 |
| Project end | May 31, 2028 |
| Funding year | 2023 |
| Award (this year) | $7,897,996 |
| NIH project number | 1C06OD035989-01 |
| Project ID | NIH-10793133 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals interested in biotechnology advancements and those affected by conditions that could be addressed through innovative therapies developed in this incubator.
✕Less likely to help
Patients who are not involved in or affected by biotechnology or pharmaceutical advancements may not receive direct benefits from this research.
What this research studies
The UPR Center for Incubator and Technology Transfer (UPRCITT) aims to create a collaborative environment for scientific research at the University of Puerto Rico. This initiative will involve outfitting a dedicated space within the Molecular Sciences Research Center, providing access to advanced instrumentation and facilities. Researchers will have the opportunity to work alongside experts in various fields, including nanotechnology and vaccine development, fostering innovation and economic growth in Puerto Rico. The center will also support the development of new businesses and job opportunities in the biotech and pharmaceutical sectors.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in biotechnology and economic development, benefiting patients through improved healthcare solutions.
How similar studies have gone: Similar initiatives in other regions have successfully fostered innovation and economic growth, suggesting a strong potential for success in this novel approach.
Where this research is happening
-
University of Puerto Rico
San Juan, United States Active
Researchers
- Principal investigator: Lasalde-Dominicci, Jose Antonio — University of Puerto Rico
- Study coordinator: Lasalde-Dominicci, Jose Antonio
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.